Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Gemcitabine in Veterinary Oncology: Limited and Protocol-Specific Evidence
Gemcitabine is an intravenous antimetabolite considered in selected veterinary protocols, where evidence and toxicity must be reviewed for the exact diagnosis.
Read moreTaxane Chemotherapy: Formulation, Infusion, and Evidence Questions
Taxanes disrupt microtubule dynamics, but formulation, infusion reactions, species experience, and veterinary evidence differ enough that product names are not interchangeable.
Read moreNamed profile Ifosfamide in Veterinary Oncology: Uroprotection and Organ-Safety ProfileRepresentative category illustration – no product packaging is shown.Ifosfamide in Veterinary Oncology: Uroprotection and Organ-Safety Profile
ifosfamide is covered as oxazaphosphorine alkylating agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy ProfileRepresentative category illustration – no product packaging is shown.Streptozotocin for Canine Insulinoma: Narrow-Indication Chemotherapy Profile
streptozotocin is covered as nitrosourea antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Dacarbazine in Veterinary Oncology: Infusion and Gastrointestinal-Risk ProfileRepresentative category illustration – no product packaging is shown.Dacarbazine in Veterinary Oncology: Infusion and Gastrointestinal-Risk Profile
dacarbazine is covered as triazene antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile 5-Fluorouracil in Veterinary Oncology: Critical Feline Toxicity WarningRepresentative category illustration – no product packaging is shown.5-Fluorouracil in Veterinary Oncology: Critical Feline Toxicity Warning
5-fluorouracil (5-FU) is covered as fluoropyrimidine antimetabolites; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Bleomycin in Veterinary Oncology: Local, Intracavitary and Pulmonary-Risk ProfileRepresentative category illustration – no product packaging is shown.Bleomycin in Veterinary Oncology: Local, Intracavitary and Pulmonary-Risk Profile
bleomycin is covered as antineoplastic glycopeptide antibiotics; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Vinorelbine in Veterinary Oncology: Lung-Tumour and Marrow-Safety ProfileRepresentative category illustration – no product packaging is shown.Vinorelbine in Veterinary Oncology: Lung-Tumour and Marrow-Safety Profile
vinorelbine is covered as vinca alkaloid antimitotics; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History ProfileRepresentative category illustration – no product packaging is shown.Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History Profile
paclitaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Docetaxel in Veterinary Oncology: Limited-Evidence Taxane ProfileRepresentative category illustration – no product packaging is shown.Docetaxel in Veterinary Oncology: Limited-Evidence Taxane Profile
docetaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Representative category illustration – not the named product or a real patient.Feline CMOP for Intermediate- to Large-Cell Lymphoma
cyclophosphamide, mitoxantrone, vincristine and prednisolone is covered as multi-agent feline lymphoma chemotherapy protocol, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more